ACM
IART icon

AUA Capital Management’s Integra LifeSciences IART Stock Holding History

AUA Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-81
Closed -$4.54K – 195
2022
Q4 		$4.54K Buy
81
+39
+93% +$1.99K ﹤0.01% 190
2022
Q3 		$2K Hold
42
– – ﹤0.01% 261
2022
Q2 		$2K Hold
42
– – ﹤0.01% 275
2022
Q1 		$3K Buy
42
+5
+14% +$329 ﹤0.01% 250
2021
Q4 		$2K Buy
37
+3
+9% +$203 ﹤0.01% 282
2021
Q3 		$2K Buy
34
+14
+70% +$989 ﹤0.01% 276
2021
Q2 		$1K Hold
20
– – ﹤0.01% 313
2021
Q1 		$1K Hold
20
– – ﹤0.01% 321
2020
Q4 		$1K Buy
20
+14
+233% +$753 ﹤0.01% 315
2020
Q3 		$0 Buy
+6
New +$285 ﹤0.01% 340

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AUA Capital Management's IART Position: Q1 2023 in Review

AUA Capital Management sold out of Integra LifeSciences (IART) in Q1 2023, closing a stake of 81 shares — an estimated $4.54K sold.

AUA Capital Management first reported a position in IART in Q3 2020 and held it in 10 quarters. The position peaked at $4.54K in Q4 2022. 279 funds tracked by Wall St. Rank hold IART as of Q1 2023.

  • AUA Capital Management reported no remaining Integra LifeSciences position as of Q1 2023 after selling out during the quarter.
  • AUA Capital Management sold 81 Integra LifeSciences shares in Q1 2023, an estimated $4.54K.
  • AUA Capital Management first reported a position in Integra LifeSciences in Q3 2020 and held it in 10 quarters.
  • AUA Capital Management's Integra LifeSciences position peaked at $4.54K in Q4 2022.
  • 279 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2023.

Based on AUA Capital Management's 13F filing for Q1 2023, filed 20 Apr 2023.